1 / 18

Neoplasms of the bladder

Neoplasms of the bladder. Classification. Primary Benign: papilloma Malignant: TCC, SCC, adenocarcinoma Secondary. Carcinoma of the bladder. ❏ epidemiology • male : female = 3:1 • mean age at diagnosis is 65 years • second most common urologic cancer. Carcinoma of the bladder.

natalya
Download Presentation

Neoplasms of the bladder

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Neoplasms of the bladder

  2. Classification • Primary • Benign: papilloma • Malignant: TCC, SCC, adenocarcinoma • Secondary

  3. Carcinoma of the bladder ❏ epidemiology • male : female = 3:1 • mean age at diagnosis is 65 years • second most common urologic cancer

  4. Carcinoma of the bladder ❏ classification • transitional cell carcinoma (TCC) >90% • squamous cell carcinoma (SCC) 5-7% • adenocarcinoma 1% • others < 1%

  5. Carcinoma of the bladder ❏ risk factors • smoking (main factor – implicated in 60% of new cases) • chemicals – naphthylamines, benzidine, tryptophan metabolites • cyclophosphamide • phenacetin metabolites • Schistosoma hematobium (associated with SCC) • chronic irritation (cystitis, chronic catheterization, bladder stones), associated with SCC

  6. Carcinoma of the bladder ❏ Spread • Direct: commonest type • Lymphatic: occurs only when the tumour has invaded the perivesical tissue • Hematogenous: uncommon • Allantotic

  7. Carcinoma of the bladder ❏ symptoms and signs • hematuria (85-90%) • pain (50%) • clot retention (17%) • no symptoms (20%) • occult hematuria • irritative urinary symptoms - consider carcinoma in situ • palpable mass on bimanual exam -> likely muscle invasion • hepatomegaly, lymphadenopathy if metastases • lower extremity lymphedema if local advancement or lymphatic spread

  8. Carcinoma of the bladder ❏ investigation • urinalysis, urine C+S, urine cytology (sensitivity increases as grade/stage increases) • ultrasound • cystoscopy with bladder washings (gold standard) • new advances with specific bladder tumour markers (NMP-22, BTA, Immunocyt, FDP) • intravenous pyelogram (IVP) • for invasive disease – CT or MRI, chest x-ray, liver function tests (metastatic work-up)

  9. ❏ stages of transitional cell carcinoma at diagnosis • superficial papillary (75%) -> >80% overall survival • 15% of these will progress to invasive TCC • the majority of these patients will have recurrence • invasive (25%) -> 50-60% 5-year survival • 85% have no prior history of superficial TCC • 15% have occult metastases at diagnosis • common sites of metastasis: lymph nodes, lung, peritoneum, liver • carcinoma in situ • may progress to invasive TCC

  10. Carcinoma of the bladder ❏ grading • Grade 1: Well-differentiated (10% invasive) • Grade 2: Moderately differentiated (50% invasive) • Grade 3: Poorly differentiated (80% invasive)

  11. Carcinoma of the bladder ❏ TNM classification • Ta noninvasive papillary carcinoma • Tis carcinoma in situ; flat tumour • T1 tumour invades submucosa/lamina propria • T2a tumour invades superficial muscle • T2b tumour invades deep muscle • T3 tumour invades perivesical fat • T4a adjacent organ involvement; prostate, uterus or vagina • T4b adjacent organ involvement; pelvic wall or abdominal wall • N, M status: as for renal cell carcinoma

  12. Transitional Cell Carcinoma of Bladder

  13. Treatment • Superficial disease (Tis, Ta, T1): • TURBT +/– intravesical chemo-/ immuno -therapy (e.g. BCG, thiotepa, mitomycin C) adjuvantly to decrease recurrence rate • invasive disease (T2a, T2b, T3) • radical cystectomy + pelvic lymphadenectomy with urinary diversion and/or irradiation • advanced/metastatic disease (T4a, T4b, N+, M+) • initial systemic chemotherapy +/– irradiation

  14. Cystectomy • Partial • Total

  15. Partial cystectomy • Tumour along with the surrounding 1 inch of healthy margin of the bladder wall is resected in its entire thickness

  16. Total cystectomy • Removal of the entire bladder, together with the seminal vesicles & the prostate • Urinary diversion achieved by: • Valve rectal pouch - modified ureterosigmoidostomy • Ileal conduit • Neo-bladder

More Related